 IRVINE, Calif., Aug. 11, 2021 GLOBE NEWSWIRE -- Biomerica Inc. NASDAQ: BMRA announced today that the Japanese Patent Office has issued a notice of allowance for Biomericas first patent pertaining to a revolutionary new treatment option for patients suffering from depression. Specifically, this allowed patent contains broad claims that enables physicians to identify patient specific foods e.g. salmon, milk, shrimp, broccoli, chickpeas, etc., that when removed from the patients diet, may alleviate or improve an individuals depression symptoms. 